PRESS RELEASE published on 09/05/2024 at 09:00, 2 months 16 days ago Biotest AG opens 13th plasma collection center in Germany Biotest AG opens 13th plasma collection center in Germany to ensure long-term plasma supply. State-of-the-art center in Karlsruhe operated by Plasma Service Europe GmbH, a subsidiary of Biotest AG Donations Germany Biotest AG Plasma Collection Center Plasma Service Europe GmbH
BRIEF published on 08/28/2024 at 09:05, 2 months 24 days ago Le Dr Jörg Schüttrumpf démissionne du conseil d'administration de Biotest AG Conseil D'administration Biotest AG Développement De Produits Jörg Schüttrumpf Groupe Grifols
BRIEF published on 08/28/2024 at 09:05, 2 months 24 days ago Dr. Jörg Schüttrumpf Resigns from Biotest AG Management Board Management Board Biotest AG Product Development Jörg Schüttrumpf Grifols Group
PRESS RELEASE published on 08/28/2024 at 09:00, 2 months 24 days ago Dr. Jörg Schüttrumpf resigns from the Management Board of Biotest AG Dr. Jörg Schüttrumpf resigns as Chief Scientific Officer of Biotest AG to focus on role as Chief Scientific Innovation Officer of Grifols Group, effective August 31, 2024 Resignation Management Board Biotest AG Grifols Group Dr. Jörg Schüttrumpf
BRIEF published on 08/06/2024 at 09:05, 3 months 15 days ago Biotest voit ses ventes augmenter de 35 % au premier semestre 2024 Résultats Financiers Hausse Des Revenus Approbation De La FDA Biotest Yimmugo®
BRIEF published on 08/06/2024 at 09:05, 3 months 15 days ago Biotest Sees 35% Sales Spike in First Half of 2024 Financial Results Revenue Growth FDA Approval Biotest Yimmugo®
PRESS RELEASE published on 08/06/2024 at 09:00, 3 months 15 days ago Biotest increases sales in the first half of 2024 by 35% to Euro 372 million Biotest AG reports 35% sales increase to Euro 372 million in H1 2024. EBIT reaches Euro 78.4 million. FDA approves Yimmugo® and BNL facility. Positive revenue and earnings growth Revenue Growth FDA Approval Sales Increase Biotest AG H1 2024
BRIEF published on 07/30/2024 at 08:05, 3 months 22 days ago Biotest Reports 35% Increase in Sales for First Half of 2024 Financial Results Revenue Increase FDA Approval Sales Growth Biotest AG
BRIEF published on 07/30/2024 at 08:05, 3 months 22 days ago Biotest annonce une augmentation de 35 % de ses ventes pour le premier semestre 2024 Résultats Financiers Approbation De La FDA La Croissance Des Ventes Augmentation Des Revenus Biotest SA
PRESS RELEASE published on 07/30/2024 at 08:00, 3 months 22 days ago Biotest increases sales in the first half of 2024 by 35% to Euro 372 million Biotest AG increases sales by 35% to Euro 372 million in the first half of 2024. EBIT reaches €78.4 million. FDA approval received. Strategic deal with Kedrion estimated to yield $1 billion in 7 years FDA Approval EBIT Sales Increase Biotest AG €372 Million
Published on 11/21/2024 at 16:30, 40 minutes ago The Rise of DINKs: Dual-Income Couples Without Kids Redefine Financial Priorities in America
Published on 11/21/2024 at 16:01, 1 hour 9 minutes ago Career Certified Extends Its Investment in the Fast-Growing Architecture, Engineering, and Construction (AEC) Professionals Market with Acquisition of My Contractors License
Published on 11/21/2024 at 16:00, 1 hour 10 minutes ago Financial Independence Group Announces Exclusive Partnership With Power of Zero and Tax-Free Retirement Expert David McKnight
Published on 11/21/2024 at 16:00, 1 hour 10 minutes ago Wiz Acquires Dazz to Revolutionize Cloud Security Remediation
Published on 11/21/2024 at 16:00, 1 hour 10 minutes ago Isaac Ullatil Joins Wellstack Board of Directors
Published on 11/21/2024 at 17:01, 9 minutes ago Original-Research: Delticom AG (von Montega AG): Kaufen
Published on 11/21/2024 at 15:41, 1 hour 28 minutes ago Edison issues report on Murray Income Trust (MUT)
Published on 11/21/2024 at 06:58, 10 hours 12 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 10 hours 12 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 10 hours 12 minutes ago Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 21 hours 2 minutes ago Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 21 hours 50 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
